One of the most common statements I hear from life sciences CEOs is:
“We’re looking for strategic investors.”
Biotech founders say it.
Medtech founders say it.
Diagnostics founders say it.
Digital health founders say it.
Over the past two decades, my team and I have organized nearly 500 investor events, reviewed hundreds of life sciences companies, and spent countless hours with founders, investors, family offices, venture capital firms, corporate development teams, and strategic partners.
Along the way, I’ve noticed a pattern.